Medizinische Universität Graz - Research portal

Logo MUG Resarch Portal

Publications

Search Items: SKIN NEOPLASMS - DRUG THERAPY , . hits: 75

2019

Woltsche, N; El-Shabrawi-Caelen, L; Deinlein, T; Kupsa, R; Gschwandtner, M; Hofmann-Wellenhof, R; Zalaudek, I [Eruptive epidermoid cysts after imiquimod treatment of recurrent basal cell carcinoma : A case report].
Hautarzt. 2019; 70(5):363-366 (- Case Report) [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2018

Giuffrida, R; Kashofer, K; Dika, E; Patrizi, A; Baraldi, C; Di Meo, N; Zalaudek, I Fast growing melanoma following treatment with vismodegib for locally advanced basal cell carcinomas: report of two cases.
Eur J Cancer. 2018; 91(2):177-179 (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

Kreuter, A; Pantelaki, I; Michalowitz, AL; Wieland, U; Cerroni, L; Oellig, F; Tigges, C CD30-positive primary cutaneous anaplastic large cell lymphoma with coexistent pseudocarcinomatous hyperplasia.
Clin Exp Dermatol. 2018; 43(5):585-588 (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

Menzer, C; Beedgen, B; Rom, J; Duffert, CM; Volckmar, AL; Sedlaczek, O; Richtig, E; Enk, A; Jäger, D; Hassel, JC Immunotherapy with ipilimumab plus nivolumab in a stage IV melanoma patient during pregnancy.
Eur J Cancer. 2018; 104(2):239-242 (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

2017

Petrella, TM; Robert, C; Richtig, E; Miller, WH; Masucci, GV; Walpole, E; Lebbe, C; Steven, N; Middleton, MR; Hille, D; Zhou, W; Ibrahim, N; Cebon, J Patient-reported outcomes in KEYNOTE-006, a randomised study of pembrolizumab versus ipilimumab in patients with advanced melanoma.
EUR J CANCER. 2017; 86(5): 115-124. [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Urech, M; Kyrgidis, A; Argenziano, G; Reggiani, C; Moscarella, E; Longo, C; Alfano, R; Zalaudek, I; Lallas, A Dermoscopic Ulceration is a Predictor of Basal Cell Carcinoma Response to Imiquimod: A Retrospective Study.
Acta Derm Venereol. 2017; 97(1):117-119 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2016

Goldinger, SM; Gobbi Bischof, S; Fink-Puches, R; Klemke, CD; Dréno, B; Bagot, M; Dummer, R Efficacy and Safety of APO866 in Patients With Refractory or Relapsed Cutaneous T-Cell Lymphoma: A Phase 2 Clinical Trial.
JAMA Dermatol. 2016; 152(7):837-839 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Kadletz, L; Bigenzahn, J; Thurnher, D; Stanisz, I; Erovic, BM; Schneider, S; Schmid, R; Seemann, R; Birner, P; Heiduschka, G Evaluation of Polo-like kinase 1 as a potential therapeutic target in Merkel cell carcinoma.
Head Neck. 2016; 38 Suppl 1(8):E1918-E1925
Web of Science PubMed FullText FullText_MUG

 

Lee, SB; Weide, B; Ugurel, S; Mössner, R; Enk, A; Hassel, JC Vemurafenib-induced granuloma annulare.
J Dtsch Dermatol Ges. 2016; 14(3):305-308 (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

Ritter, C; Fan, K; Paulson, KG; Nghiem, P; Schrama, D; Becker, JC Reversal of epigenetic silencing of MHC class I chain-related protein A and B improves immune recognition of Merkel cell carcinoma.
Sci Rep. 2016; 6:21678-21678 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2015

Robert, C; Schachter, J; Long, GV; Arance, A; Grob, JJ; Mortier, L; Daud, A; Carlino, MS; McNeil, C; Lotem, M; Larkin, J; Lorigan, P; Neyns, B; Blank, CU; Hamid, O; Mateus, C; Shapira-Frommer, R; Kosh, M; Zhou, H; Ibrahim, N; Ebbinghaus, S; Ribas, A; KEYNOTE-006 investigators Pembrolizumab versus Ipilimumab in Advanced Melanoma.
N Engl J Med. 2015; 372(26):2521-2532 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Ugurel, S; Loquai, C; Kähler, K; Hassel, J; Berking, C; Zimmer, L; Haubitz, I; Satzger, I; Müller-Brenne, T; Mikhaimer, NC; Becker, JC; Kilian, KJ; Schadendorf, D; Heinzerling, L; Kaatz, M; Utikal, J; Göppner, D; Pföhler, C; Pflugfelder, A; Mössner, R; Gutzmer, R; Dermatologic Cooperative Oncology Group (DeCOG) A multicenter DeCOG study on predictors of vemurafenib therapy outcome in melanoma: pretreatment impacts survival.
Ann Oncol. 2015; 26(3):573-582 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2014

Apalla, Z; Lallas, A; Tzellos, T; Sidiropoulos, T; Lefaki, I; Trakatelli, M; Sotiriou, E; Lazaridou, E; Evangelou, G; Patsatsi, A; Kyrgidis, A; Stratigos, A; Zalaudek, I; Argenziano, G; Ioannides, D Applicability of dermoscopy for evaluation of patients' response to nonablative therapies for the treatment of superficial basal cell carcinoma.
Br J Dermatol. 2014; 170(4):809-815 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Hackl, G; Ratschek, M; Gary, T; Belaj, K; Brodmann, M; Seinost, G Progressive jugular vein thrombosis in cutaneous extramedullary plasmacytoma.
Eur J Haematol. 2014; 93(2):177-178 (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

Joshi, N; Shirsath, N; Singh, A; Joshi, KS; Banerjee, R Endogenous lung surfactant inspired pH responsive nanovesicle aerosols: pulmonary compatible and site-specific drug delivery in lung metastases.
Sci Rep. 2014; 4:7085-7085 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Knobler, R; Berlin, G; Calzavara-Pinton, P; Greinix, H; Jaksch, P; Laroche, L; Ludvigsson, J; Quaglino, P; Reinisch, W; Scarisbrick, J; Schwarz, T; Wolf, P; Arenberger, P; Assaf, C; Bagot, M; Barr, M; Bohbot, A; Bruckner-Tuderman, L; Dreno, B; Enk, A; French, L; Gniadecki, R; Gollnick, H; Hertl, M; Jantschitsch, C; Jung, A; Just, U; Klemke, CD; Lippert, U; Luger, T; Papadavid, E; Pehamberger, H; Ranki, A; Stadler, R; Sterry, W; Wolf, IH; Worm, M; Zic, J; Zouboulis, CC; Hillen, U Guidelines on the use of extracorporeal photopheresis.
J Eur Acad Dermatol Venereol. 2014; 28 Suppl 1:1-37 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Kopera, D; Kerl, H Visualization and Treatment of Subclinical Actinic Keratoses with Topical Imiquimod 5% Cream: An Observational Study
BIOMED RES INT. 2014; 135916 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Paulson, KG; Tegeder, A; Willmes, C; Iyer, JG; Afanasiev, OK; Schrama, D; Koba, S; Thibodeau, R; Nagase, K; Simonson, WT; Seo, A; Koelle, DM; Madeleine, M; Bhatia, S; Nakajima, H; Sano, S; Hardwick, JS; Disis, ML; Cleary, MA; Becker, JC; Nghiem, P Downregulation of MHC-I expression is prevalent but reversible in Merkel cell carcinoma.
Cancer Immunol Res. 2014; 2(11):1071-1079 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Schrama, D; Groesser, L; Ugurel, S; Hafner, C; Pastrana, DV; Buck, CB; Cerroni, L; Theiler, A; Becker, JC Presence of human polyomavirus 6 in mutation-specific BRAF inhibitor-induced epithelial proliferations.
JAMA Dermatol. 2014; 150(11):1180-1186 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Weide, B; Eigentler, TK; Pflugfelder, A; Zelba, H; Martens, A; Pawelec, G; Giovannoni, L; Ruffini, PA; Elia, G; Neri, D; Gutzmer, R; Becker, JC; Garbe, C Intralesional treatment of stage III metastatic melanoma patients with L19-IL2 results in sustained clinical and systemic immunologic responses.
Cancer Immunol Res. 2014; 2(7):668-678 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2013

Becker, JC; Schrama, D; The Dark Side of Cyclophosphamide: Cyclophosphamide-Mediated Ablation of Regulatory T Cells.
J INVEST DERMATOL. 2013; 133(6): 1462-1465. [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Degen, A; Weichenthal, M; Ugurel, S; Trefzer, U; Kilian, K; Garbe, C; Egberts, F; Poppe, LM; Hauschild, A; Gutzmer, R Cutaneous side effects of combined therapy with sorafenib and pegylated interferon alpha-2b in metastatic melanoma (phase II DeCOG trial).
J Dtsch Dermatol Ges. 2013; 11(9):846-853
Web of Science PubMed FullText FullText_MUG

 

Duvic, M; Dummer, R; Becker, JC; Poulalhon, N; Romero, PO; Bernengo, MG; Lebbe, C; Assaf, C; Squier, M; Williams, D; Marshood, M; Tai, F; Prince, HM; Panobinostat activity in both bexarotene-exposed and -naive patients with refractory cutaneous T-cell lymphoma: Results of a phase II trial.
EUR J CANCER. 2013; 49(2): 386-394.
Web of Science PubMed FullText FullText_MUG

 

Kruit, WH; Suciu, S; Dreno, B; Mortier, L; Robert, C; Chiarion-Sileni, V; Maio, M; Testori, A; Dorval, T; Grob, JJ; Becker, JC; Spatz, A; Eggermont, AM; Louahed, J; Lehmann, FF; Brichard, VG; Keilholz, U Selection of immunostimulant AS15 for active immunization with MAGE-A3 protein: results of a randomized phase II study of the European Organisation for Research and Treatment of Cancer Melanoma Group in Metastatic Melanoma.
J Clin Oncol. 2013; 31(19): 2413-2420. [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

O'Day, SJ; Eggermont, AMM; Chiarion-Sileni, V; Kefford, R; Grob, JJ; Mortier, L; Robert, C; Schachter, J; Testori, A; Mackiewicz, J; Friedlander, P; Garbe, C; Ugurel, S; Collichio, F; Guo, W; Lufkin, J; Bahcall, S; Vukovic, V; Hauschild, A; Final Results of Phase III SYMMETRY Study: Randomized, Double-Blind Trial of Elesclomol Plus Paclitaxel Versus Paclitaxel Alone As Treatment for Chemotherapy-Naive Patients With Advanced Melanoma.
J Clin Oncol. 2013; 31(9):1211-1218 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Puttgen, KB; Summerer, B; Schneider, J; Cohen, BA; Boss, EF; Bauman, NM Cardiovascular and blood glucose parameters in infants during propranolol initiation for treatment of symptomatic infantile hemangiomas.
Ann Otol Rhinol Laryngol. 2013; 122(9): 550-554.
Web of Science PubMed FullText FullText_MUG

 

Richtig, E; Schrama, D; Ugurel, S; Fried, I; Niederkorn, A; Massone, C; Becker, JC BRAF mutation analysis of only one single metastatic lesion can restrict the treatment of melanoma - a case report.
Br J Dermatol. 2013; 168(2):428-430 (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

Santos, M; Nogueira, L; Talahri, C; Massone, C; Cerroni, L; Mira, MT; Talhari, S Hydroa vacciniforme-like lymphoma in a patient from the Brazilian Amazon.
Int J Dermatol. 2013; 52(5): 641-643. (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

2012

Dummer, R; Quaglino, P; Becker, JC; Hasan, B; Karrasch, M; Whittaker, S; Morris, S; Weichenthal, M; Stadler, R; Bagot, M; Cozzio, A; Bernengo, MG; Knobler, R; Prospective International Multicenter Phase II Trial of Intravenous Pegylated Liposomal Doxorubicin Monochemotherapy in Patients With Stage IIB, IVA, or IVB Advanced Mycosis Fungoides: Final Results From EORTC 21012.
J CLIN ONCOL. 2012; 30(33): 4091-4097. [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Longo, C; Casari, A; Pepe, P; Moscarella, E; Zalaudek, I; Argenziano, G; Pellacani, G Confocal microscopy insights into the treatment and cellular immune response of Basal cell carcinoma to photodynamic therapy.
Dermatology. 2012; 225(3):264-270
Web of Science PubMed FullText FullText_MUG

 

Tiodorovic-Zivkovic, D; Zalaudek, I; Longo, C; De Pace, B; Albertini, G; Argenziano, G Successful treatment of two invasive squamous cell carcinomas with topical 5% imiquimod cream in elderly patients.
Eur J Dermatol. 2012; 22(4):579-580 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2011

Akkilic-Materna, M; Massone, C; Komericki, P Imiquimod and lymphatic field clearance: a new hypothesis based on a remote immune action on skin cancer.
Acta Derm Venereol. 2011; 91(4):432-435 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Gulia, A; Saggini, A; Wiesner, T; Fink-Puches, R; Argenyi, Z; Ferrara, G; Müller, CS; Vale, E; Cerroni, L Clinicopathologic features of early lesions of primary cutaneous follicle center lymphoma, diffuse type: implications for early diagnosis and treatment.
J Am Acad Dermatol. 2011; 65(5):991-1000
Web of Science PubMed FullText FullText_MUG

 

Ponte, P; Serrao, V; Viana, I; Vale, E; Joao, A; Cerroni, L Borderline CD30+ cutaneous lymphoproliferative disorder: report of a case with expression of cytotoxic markers and response to clarithromycin.
J CUTANEOUS PATHOL. 2011; 38(3): 301-305. [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Wobser, M; Kneitz, H; Bröcker, EB; Becker, JC Primary cutaneous diffuse large B-cell lymphoma, leg-type, treated with a modified R-CHOP immunochemotherapy - diagnostic and therapeutic challenges.
J Dtsch Dermatol Ges. 2011; 9(3):204-210
Web of Science PubMed FullText FullText_MUG

 

2010

Kopp, KL; Dabelsteen, S; Krejsgaard, T; Eriksen, KW; Geisler, C; Becker, JC; Wasik, M; Odum, N; Woetmann, A COX-2 is a novel target in therapy of mycosis fungoides.
Leukemia. 2010; 24(12):2127-2129 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Kopp, KLM; Kauczok, CS; Lauenborg, B; Krejsgaard, T; Eriksen, KW; Zhang, Q; Wasik, MA; Geisler, C; Ralfkiaer, E; Becker, JC; Odum, N; Woetmann, A COX-2-dependent PGE(2) acts as a growth factor in mycosis fungoides (MF)
LEUKEMIA. 2010; 24(6): 1179-1185. [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Terheyden, P; Houben, R; Pajouh, P; Thorns, C; Zillikens, D; Becker, JC Response to imatinib mesylate depends on the presence of the V559A-mutated KIT oncogene.
J Invest Dermatol. 2010; 130(1):314-316 (- Case Report) [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Whittaker, SJ; Demierre, MF; Kim, EJ; Rook, AH; Lerner, A; Duvic, M; Scarisbrick, J; Reddy, S; Robak, T; Becker, JC; Samtsov, A; McCulloch, W; Kim, YH Final results from a multicenter, international, pivotal study of romidepsin in refractory cutaneous T-cell lymphoma.
J Clin Oncol. 2010; 28(29):4485-4491 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Zampetti, A; Gnarra, M; Linder, D; Antuzzi, D; Cataldi, L; Tulli, A; Feliciani, C Early-onset basal cell carcinoma in a case of Ivemark syndrome.
Eur J Dermatol. 2010; 20(6): 845-846. (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

2009

Haxhija, EQ; Lackner, H; Höllwarth, ME Medical treatment of children with hemangiomas and its limitations
Handchir Mikrochir Plast Chir. 2009; 41(2): 78-82.
Web of Science PubMed FullText FullText_MUG

 

2008

Hauschild, A; Trefzer, U; Garbe, C; Kaehler, KC; Ugurel, S; Kiecker, F; Eigentler, T; Krissel, H; Schott, A; Schadendorf, D Multicenter phase II trial of the histone deacetylase inhibitor pyridylmethyl-N-{4-[(2-aminophenyl)-carbamoyl]-benzyl}-carbamate in pretreated metastatic melanoma.
Melanoma Res. 2008; 18(4):274-278
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Houben, R; Wischhusen, J; Menaa, F; Synwoldt, P; Schrama, D; Brocker, EB; Becker, JC Melanoma stem cells: targets for successful Therapy?
J DTSCH DERMATOL GES. 2008; 6(7): 541-547.
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Schrama, D; Hauschild, A; Becker, JC Immunmodulatory antibodies in the treatment of skin cancer
Hautarzt. 2008; 59(10):806-813
Web of Science PubMed FullText FullText_MUG

 

Spieth, K; Kaufmann, R; Dummer, R; Garbe, C; Becker, JC; Hauschild, A; Tilgen, W; Ugurel, S; Beyeler, M; Bröcker, EB; Kaehler, KC; Pföhler, C; Gille, J; Leiter, U; Schadendorf, D Temozolomide plus pegylated interferon alfa-2b as first-line treatment for stage IV melanoma: a multicenter phase II trial of the Dermatologic Cooperative Oncology Group (DeCOG).
Ann Oncol. 2008; 19(4):801-806 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Ugurel, S In vitro drug sensitivity profiling in melanoma.
J Dtsch Dermatol Ges. 2008; 6(7):611-611
PubMed FullText FullText_MUG

 

2007

Terheyden, P; Hofmann, MA; Weininger, M; Brocker, EB; Becker, JC Anti-vascular endothelial growth factor antibody bevacizumab in conjunction with chemotherapy in metastasising melanoma.
J Cancer Res Clin Oncol. 2007; 133(11):897-901 (- Case Report)
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Terheyden, P; Kortum, AK; Schulze, HJ; Durani, B; Remling, R; Mauch, C; Junghans, V; Schadendorf, D; Beiteke, U; Junger, M; Becker, JC; Brocker, EB Chemoimmunotherapy for cutaneous melanoma with dacarbazine and epifocal contact sensitizers: results of a nationwide survey of the German Dermatologic Co-operative Oncology Group.
J Cancer Res Clin Oncol. 2007; 133(7):437-444
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Ugurel, S Targeted therapy of dermatofibrosarcoma with imatinib.
J Dtsch Dermatol Ges. 2007; 5(3):261-261
PubMed FullText FullText_MUG

 

Wolf, IH; Kodama, K; Cerroni, L; Kerl, H Nature of inflammatory infiltrate in superficial cutaneous malignancies during topical imiquimod treatment.
Am J Dermatopathol. 2007; 29(3):237-241
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Show the next 50 results of search
© Med Uni GrazImprint